How Gene Therapy Companies are Transforming Rare Disease Cure?
Historically, developing rare disease cures and treatments has been challenging. The small, globally dispersed patient population made it difficult and expensive to bring together enough individuals for a clinical-stage trial. The small patient population of fewer than 1% also made it impossible to recoup the investment in research and development costs required for a cure […]